3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
2
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
6
Gastrointestinal
5
Thoracic
3
Genitourinary
3
Lymphoid
2
CNS
2
Plasma cell
1
Other hematologic neoplasm
1
Other
1
Head & Neck
1
Gynecologic
1
Endocrine
1
Conditions
Multiple Myeloma
323
Lymphoma
86
Leukemia
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Lymphoma, Non-Hodgkin
62
Hodgkin Disease
60
Leukemia, Lymphocytic, Chronic, B-Cell
58
Neoplasms, Plasma Cell
56
Leukemia, Myeloid, Acute
50
Lymphoma, Mantle-Cell
47
Myelodysplastic Syndromes
44
Lymphoma, Follicular
44
Myeloproliferative Disorders
42
Lymphoma, Large B-Cell, Diffuse
42
Lymphoma, B-Cell, Marginal Zone
40
Burkitt Lymphoma
40
Neoplasms
39
Lymphoma, Large-Cell, Immunoblastic
38
Primary Myelofibrosis
37
Lymphoma, T-Cell, Cutaneous
35
Sezary Syndrome
33
Mycosis Fungoides
33
Leukemia, Myeloid, Chronic-Phase
33
Leukemia, Myeloid, Accelerated Phase
33
Congenital Abnormalities
31
Hematologic Neoplasms
30
Blast Crisis
30
Leukemia, Hairy Cell
29
Breast Neoplasms
29
Leukemia, Myelomonocytic, Chronic
27
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Fasting
×
Plasma cell
×
Clear all
NCT05565638
2025-09-25
PROFAST
Dana-Farber Cancer Institute
Phase NA
Completed
23 enrolled